English 
Francais 
عربي 
Cancer : poor Europe...
[mis à jour le 1 August 2006 à 09h40]
Public funding for cancer research is seven times greater in the US than in Europe. This is the conclusion from a European study published in the journal PloS Medicine. A fox in the henhouse.
However, French President Jacques Chirac can take some (bitter) satisfaction. It is uncertain if this is a direct consequence of the National Cancer Plan whose launch was heavily publicised 4 years ago, but France was rated as third "investor" in this area. Right behind Great Britain and Germany, and far in front of the 4th , that is...the European Commission.
In fact, European politics of cancer research seem to cruelly suffer in comparison to Uncle Sam’s. "Seem" only because this study has some surprising biases. In particular, the inclusion of countries such as Bulgaria, Iceland, Israel, Romania, Slovenia and Turkey in "Europe". Nevertheless, the authors stress that "Public cancer funding is crucial. It is important to implement prevention policies, find new treatments and improve patients’ quality of life". A perfectly logical reasoning that leaders of Europe-the real one - would gain from including in their reflections concerning priorities.
Source: PloS Medicine, July 17, 2006
Print this article
Share on Facebook
Share on Twitter
Send to a friend
Convert to pdf
Copyright Authorization
10 article(s)
New hope in the treatment of lung cancer… and other cancers too?
Gardasil: developing countries are promised they will not have to wait!
Curcuma, the root that can save lives?
Room in the hospital for beauty and well-being
Cancers: a dictionary to know it all...
Cancer: the four serial killers… and the others!
Fruit and vegetables for cancer…
Combating tumours with psychoactive drugs
